Physician profile
Jonathan Lu
NPI 1346610862
$3,934.59
in general payments reported to CMS, 2019-2025
15 companies · $94.22 in 2025
The $94.22 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $126 · 2021: $521 · 2022: $1,992 · 2023: $421 · 2024: $781 · 2025: $94.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,295.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,000.00 | 2022 | |
| Amgen INC. | $550.91 | 2024 | Tepezza |
| Horizon Therapeutics Plc | $540.30 | 2021-2023 | Tepezza |
| Genentech USA, INC. | $394.35 | 2021-2023 | Vabysmo |
| Apellis Pharmaceuticals, INC. | $364.67 | 2022-2023 | |
| Alcon Vision LLC | $337.20 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $138.29 | 2022 | |
| Abbvie INC. | $130.00 | 2024 | |
| Regeneron Pharmaceuticals, INC. | $124.15 | 2023 | |
| Hollister Incorporated | $112.18 | 2022 | |
| Stryker Corporation | $94.22 | 2025 | Core |
| Ani Pharmaceuticals, INC. | $86.40 | 2024 | Purified Cortrophin Gel |
| Zimmer Biomet Holdings, INC. | $29.96 | 2020 | |
| Gilead Sciences, INC. | $18.69 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $13.27 | 2024 | Tecnis Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.